Chronic Liver Disease (CLD)
12
4
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (12)
Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency
Identification of Patients With Advanced Chronic Diseases in Need of Palliative Care
A Clinical Trial to Assess the Pharmacokinetics, Safety, and Food Effect of AD-230 in Healthy Adults
Correlation Of EUS-SWQ And Liver Fibrosis Pathology In Chronic Liver Disease
Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers
Ultrasound Prediction of Esophageal Variceal Bleeding Risk
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
Heart Problems in Children With Chronic Liver Disease
EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG
Chronic Liver Disease and Radiation-induced Second Primary Liver Malignancy
Equivalence of New Breath AnalyzerCompared to Currently BreathID System in Assessment of Liver Function